INJ falls as downward price move accelerates amid weak momentum
Injective (INJ) is trading at $7.11, down 10.45% for the day. The price is currently above its key short-term moving average but remains below important medium-term levels, and volatility has been elevated throughout the session.
Highlights
- Nasdaq listed the Staked INJ ETF, expanding traditional investor access to Injective and including staking rewards participation.
- Injective stakers overwhelmingly back the Veyra mainnet upgrade proposal, indicating strong network support for upcoming enhancements.
- INJ/USD trades in a mixed technical setup, consolidating between $6.71 and $7.51 with modestly higher odds of further downside.
ETF launch and governance wins bolster institutional access amid selling
The launch of the Staked INJ ETF on Nasdaq marked a significant expansion of access to Injective for traditional investors, offering both exposure to INJ and participation in staking rewards, according to Coingabbar. This development is expected to improve liquidity and attract broader institutional attention. Meanwhile, Injective's Veyra mainnet upgrade proposal has secured overwhelming support from stakers, with the vote likely to pass in the coming days, signaling broad network alignment behind upcoming enhancements, according to Bloomingbit. Additionally, dYdX announced updates to its protocols for Injective deposits and withdrawals, directly impacting the operational environment for Injective network users, as reported by Coinfomania—though price action has remained under broader selling pressure.
Mixed momentum as price nears resistance and technical signals diverge
INJ/USD is currently trading above the MA-20 at $7.04, while remaining below the MA-50 at $7.61; the long-term MA-200 stands at $5.81. Immediate resistance is set at the Ichimoku Kijun level of $7.31. MACD is signaling strong selling momentum, and ADX reflects a generally bearish tone. RSI and CCI are in neutral zones. Stoch RSI is overbought, suggesting risks of near-term overheating, while Bull/Bear Power at 0.11 indicates a slight edge to buyers intraday. The Awesome Oscillator is neutral, failing to provide clear directional confirmation. This mix of technical signals underscores ongoing high volatility and uncertainty.
Mild downside bias as consolidation traps price near key levels
In the near term, INJ/USD is expected to consolidate within a price corridor of $6.71 to $7.51, reflecting typical volatility for the current environment. There is a 45% probability of an upward move and a 55% probability of a downward move, indicating a modest tilt toward further downside. Should price clear the $7.31 resistance, bullish momentum could accelerate. Conversely, decisive loss of $6.71 support would likely prompt additional selling.
Previously it was reported that Injective continued to face short- and medium-term technical headwinds despite robust protocol upgrades and strong community support. The current analysis reinforces this outlook, highlighting that elevated volatility and a modest bearish bias persist, with traders closely monitoring the $7.31 resistance and $6.71 support as pivotal levels for the next decisive move.